Skip to main content
Top
Published in: Pediatric Nephrology 6/2004

01-06-2004 | Brief Report

Generalized atherosclerosis sparing the transplanted kidney in Schimke disease

Authors: Thomas Lücke, Katja M. Marwedel, Nele K. Kanzelmeyer, Akira Hori, Gisela Offner, Hans-Heinrich Kreipe, Jochen H. H. Ehrich, Anibh M. Das

Published in: Pediatric Nephrology | Issue 6/2004

Login to get access

Abstract

Schimke-immuno-osseous dysplasia (SIOD) is a multisystem disorder caused by a mutation of the chromatin remodeling protein. The main clinical findings are spondyloepiphyseal dysplasia with dysproportional growth deficiency, nephrotic syndrome with focal and segmental glomerulosclerosis, and defective cellular immunity. Transitory ischemic attacks due to vaso-occlusive processes are still an untreatable and life-limiting complication in patients with SIOD. The underlying pathophysiology of vaso-occlusive processes in SIOD is unclear. We report the clinical and pathological findings of the eldest published patient with the severe form of SIOD, who died at the age of 23 years due to pulmonary hypertension with subsequent right heart failure. The autopsy revealed a severe generalized atherosclerosis including the brain, heart, and pulmonary arteries. However, the kidney that was transplanted at the age of 5 years showed a good graft function without glomerular sclerosis and with only minimal nephrosclerosis on histology. Thus, the absence of severe vaso-occlusive processes in the transplanted organ and in the severely atherosclerotic host may indicate that the vaso-occlusive processes in SIOD are not caused by post-transplant cardiovascular morbidity such as arterial hypertension and hyperlipidemia. Instead, vascular factors of the host such as endothelial dysfunction may explain the pathophysiology of atherosclerosis in SIOD.
Literature
1.
go back to reference Boerkoel CF, O’Neill S, Andre JL, Benke PJ, Bogdanovic R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Frund S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Ormala T, Rener-Primec Z, Weksberg R (2000) Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr 159:1–7PubMed Boerkoel CF, O’Neill S, Andre JL, Benke PJ, Bogdanovic R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Frund S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Ormala T, Rener-Primec Z, Weksberg R (2000) Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr 159:1–7PubMed
2.
go back to reference Schimke RN, Horton WA, King CR (1971) Chondroitin-6-sulphate-uria, defective cellular immunity and nephritic syndrome. Lancet II:1088–1089 Schimke RN, Horton WA, King CR (1971) Chondroitin-6-sulphate-uria, defective cellular immunity and nephritic syndrome. Lancet II:1088–1089
3.
go back to reference Schimke RN, Horton WA, King CR, Martin NL (1974) Chondroitin-6-sulphate mucopolysaccaridosis in conjunction with lymphopenia, defective cellular immunity and nephritic syndrome. Birth Defects 10:258–266PubMed Schimke RN, Horton WA, King CR, Martin NL (1974) Chondroitin-6-sulphate mucopolysaccaridosis in conjunction with lymphopenia, defective cellular immunity and nephritic syndrome. Birth Defects 10:258–266PubMed
4.
go back to reference Spranger J, Hinkel GK, Stoss H, Thoenes W, Wargowski D, Zepp F (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr 119:64–72PubMed Spranger J, Hinkel GK, Stoss H, Thoenes W, Wargowski D, Zepp F (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr 119:64–72PubMed
5.
go back to reference Ehrich JHH, Offner G, Schirg E, Hoyer PF, Helmchen U, Brodehl J (1990) Association of spondylo-epiphyseal dysplasia with nephrotic syndrome. Pediatr Nephrol 4:117–121PubMed Ehrich JHH, Offner G, Schirg E, Hoyer PF, Helmchen U, Brodehl J (1990) Association of spondylo-epiphyseal dysplasia with nephrotic syndrome. Pediatr Nephrol 4:117–121PubMed
6.
go back to reference Gilchrist DM, Harley FL (1992) Schimke immuno-osseous dysplasia. J Pediatr 120:497 Gilchrist DM, Harley FL (1992) Schimke immuno-osseous dysplasia. J Pediatr 120:497
7.
go back to reference Hashimoto K, Takeuchi A, Ieshima A, Takada M, Kasagi M (1994) Juvenile variant of Schimke immunoosseous dysplasia. Am J Med Genet 49:266–269PubMed Hashimoto K, Takeuchi A, Ieshima A, Takada M, Kasagi M (1994) Juvenile variant of Schimke immunoosseous dysplasia. Am J Med Genet 49:266–269PubMed
8.
go back to reference Ehrich JHH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J (1995) Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol 43:89–95PubMed Ehrich JHH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J (1995) Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol 43:89–95PubMed
9.
go back to reference Schmidt B, Christen HJ, Herkenrath P, Benz-Bohm G, Muller-Berghaus J, Querfeld U (1997) Cerebral complications in Schimke immuno-osseous dysplasia. Eur J Pediatr 156:789–791CrossRefPubMed Schmidt B, Christen HJ, Herkenrath P, Benz-Bohm G, Muller-Berghaus J, Querfeld U (1997) Cerebral complications in Schimke immuno-osseous dysplasia. Eur J Pediatr 156:789–791CrossRefPubMed
10.
go back to reference Boerkoel CF, Nowaczyk MJM, Blaser SI, Meschino WS, Weksberg R (1998) Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet 78:118–122CrossRefPubMed Boerkoel CF, Nowaczyk MJM, Blaser SI, Meschino WS, Weksberg R (1998) Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet 78:118–122CrossRefPubMed
11.
go back to reference Lücke T, Kemper M, Neumaier-Probst E, Bentele KHP, Spranger J, Kohlschütter A (1999) Das Moya-Moya-Phänomen bei der Immuno-Ossären Dysplasie Schimke. Monatsschr Kinderheilkd 147:904 Lücke T, Kemper M, Neumaier-Probst E, Bentele KHP, Spranger J, Kohlschütter A (1999) Das Moya-Moya-Phänomen bei der Immuno-Ossären Dysplasie Schimke. Monatsschr Kinderheilkd 147:904
12.
go back to reference Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andre JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Frund S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 30:215–220CrossRefPubMed Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andre JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Frund S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 30:215–220CrossRefPubMed
13.
go back to reference Da Fonseca MA (2000) Dental findings in the Schimke immuno-osseous dysplasia. Am J Med Genet 93:158–160CrossRefPubMed Da Fonseca MA (2000) Dental findings in the Schimke immuno-osseous dysplasia. Am J Med Genet 93:158–160CrossRefPubMed
14.
go back to reference Dhillon AS, Chapman S, Milford DV (2001) Cerebellar defect associated with Schimke immuno-osseous dysplasia. Eur J Pediatr 160:372–374CrossRefPubMed Dhillon AS, Chapman S, Milford DV (2001) Cerebellar defect associated with Schimke immuno-osseous dysplasia. Eur J Pediatr 160:372–374CrossRefPubMed
15.
go back to reference Rodrigo F, Ferrer-Canabate J, Gracia S, Tovar I, Borraja E, Tellez C, Martinez P (2001) Schimke immunoosseous dysplasia syndrome (SIOD). Pediatr Nephrol 16:606–608CrossRefPubMed Rodrigo F, Ferrer-Canabate J, Gracia S, Tovar I, Borraja E, Tellez C, Martinez P (2001) Schimke immunoosseous dysplasia syndrome (SIOD). Pediatr Nephrol 16:606–608CrossRefPubMed
16.
go back to reference Iseki K, Fukiyama K (1996) Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672–1675PubMed Iseki K, Fukiyama K (1996) Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672–1675PubMed
17.
go back to reference Goldstein S, Duhamel G, Laudat MH, Berthelier M, Hervy C, Tete MJ, Broyer M (1984) Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis? Nephron 38:87–92PubMed Goldstein S, Duhamel G, Laudat MH, Berthelier M, Hervy C, Tete MJ, Broyer M (1984) Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis? Nephron 38:87–92PubMed
18.
go back to reference Kaitilia I, Savilahti E, Ormala T (1998) Autoimmune enteropathy in Schimke immunoosseous dysplasia. Am J Med Genet 77:427–430CrossRefPubMed Kaitilia I, Savilahti E, Ormala T (1998) Autoimmune enteropathy in Schimke immunoosseous dysplasia. Am J Med Genet 77:427–430CrossRefPubMed
19.
go back to reference Kim P, Jones JD, Sundt TM (1992) High-energy phosphate levels in the cerebral artery during chronic vasospasm after arachnoidal hemorrhage. Neurosurgery 76:991–996 Kim P, Jones JD, Sundt TM (1992) High-energy phosphate levels in the cerebral artery during chronic vasospasm after arachnoidal hemorrhage. Neurosurgery 76:991–996
20.
go back to reference Clark JF, Kemp GJ, Radda GK (1995) The creatine kinase equilibrium, free [ADP] and myosin ATPase in vascular smooth muscle. J Theor Biol 173:207–211CrossRefPubMed Clark JF, Kemp GJ, Radda GK (1995) The creatine kinase equilibrium, free [ADP] and myosin ATPase in vascular smooth muscle. J Theor Biol 173:207–211CrossRefPubMed
21.
go back to reference Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012PubMed Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012PubMed
22.
go back to reference Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489–509PubMed Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489–509PubMed
23.
go back to reference Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14:753–759PubMed Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14:753–759PubMed
Metadata
Title
Generalized atherosclerosis sparing the transplanted kidney in Schimke disease
Authors
Thomas Lücke
Katja M. Marwedel
Nele K. Kanzelmeyer
Akira Hori
Gisela Offner
Hans-Heinrich Kreipe
Jochen H. H. Ehrich
Anibh M. Das
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 6/2004
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1426-z

Other articles of this Issue 6/2004

Pediatric Nephrology 6/2004 Go to the issue